Annual Interest Expense
N/A
31 December 2023
Summary:
Adaptimmune Therapeutics annual interest expense is not available.ADAP Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$1.11 M
+$583.00 K+110.84%
30 September 2024
Summary:
Adaptimmune Therapeutics quarterly interest expense is currently $1.11 million, with the most recent change of +$583.00 thousand (+110.84%) on 30 September 2024. Over the past year, it has increased by +$1.11 million (+100.00%). ADAP quarterly interest expense is now at all-time high.ADAP Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$1.64 M
+$1.11 M+210.84%
30 September 2024
Summary:
Adaptimmune Therapeutics TTM interest expense is currently $1.64 million, with the most recent change of +$1.11 million (+210.84%) on 30 September 2024. Over the past year, it has increased by +$1.64 million (+100.00%). ADAP TTM interest expense is now at all-time high.ADAP TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADAP Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +100.0% | +100.0% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ADAP Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | at high | ||||
| 5 y | 5 years | at high | at high | ||||
| alltime | all time | at high | at high |
Adaptimmune Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.11 M(+110.8%) | $1.64 M(+210.8%) |
| June 2024 | - | $526.00 K(>+9900.0%) | $526.00 K(>+9900.0%) |
| Sept 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2016 | - | $0.00 | $0.00 |
| June 2013 | $6100.00 | - | - |
FAQ
- What is the all time high annual interest expense for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics quarterly interest expense year-on-year change?
- What is Adaptimmune Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics TTM interest expense year-on-year change?
What is the all time high annual interest expense for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high annual interest expense is $6100.00
What is Adaptimmune Therapeutics quarterly interest expense?
The current quarterly interest expense of ADAP is $1.11 M
What is the all time high quarterly interest expense for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high quarterly interest expense is $1.11 M
What is Adaptimmune Therapeutics quarterly interest expense year-on-year change?
Over the past year, ADAP quarterly interest expense has changed by +$1.11 M (+100.00%)
What is Adaptimmune Therapeutics TTM interest expense?
The current TTM interest expense of ADAP is $1.64 M
What is the all time high TTM interest expense for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high TTM interest expense is $1.64 M
What is Adaptimmune Therapeutics TTM interest expense year-on-year change?
Over the past year, ADAP TTM interest expense has changed by +$1.64 M (+100.00%)